Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma.
Pignot G, Margue G, Bigot P, Lang H, Balssa L, Roubaud G, Borchiellini D, Bensalah K, Schlürmann F, Ladoire S, Parier B, Bernhard JC, Cassuto O, Albigès L, Thibault C, Ingels A, Cherifi F, Waeckel T, Flippot R, Geoffrois L, Walz J, Gravis G, Barthélémy P. Pignot G, et al. Among authors: bernhard jc. World J Urol. 2025 Jan 2;43(1):54. doi: 10.1007/s00345-024-05361-y. World J Urol. 2025. PMID: 39747746
Impact of clean intermittent self-catheterization and indwelling catheterization on perioperative outcomes in patients with urinary retention undergoing BPH surgery: A comparative monocentric retrospective study.
Denimal L, Klein C, Capon G, Alezra E, Bernhard JC, Estrade V, Blanc P, Bladou F, Robert G. Denimal L, et al. Among authors: bernhard jc. Fr J Urol. 2024 Dec 20;35(1):102851. doi: 10.1016/j.fjurol.2024.102851. Online ahead of print. Fr J Urol. 2024. PMID: 39710328
Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157).
Margue G, Klein C, Parier B, Albiges L, Pignot G, Gravis G, Bigot P, Baize N, Ingels A, Joly C, Audenet F, Vano Y, Waeckel T, Levard R, Barthelemy P, Ambrosetti D, Verkarre V, Yacoub M, Gross-Goupil M, Bernhard JC. Margue G, et al. Among authors: bernhard jc. Urol Oncol. 2024 Nov 26:S1078-1439(24)00718-X. doi: 10.1016/j.urolonc.2024.11.003. Online ahead of print. Urol Oncol. 2024. PMID: 39603878
French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer.
Bigot P, Boissier R, Khene ZE, Albigès L, Bernhard JC, Correas JM, De Vergie S, Doumerc N, Ferragu M, Ingels A, Margue G, Ouzaïd I, Pettenati C, Rioux-Leclercq N, Sargos P, Waeckel T, Barthelemy P, Rouprêt M. Bigot P, et al. Among authors: bernhard jc. Fr J Urol. 2024 Nov;34(12):102735. doi: 10.1016/j.fjurol.2024.102735. Fr J Urol. 2024. PMID: 39581661 Free article. Review.
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Graham J, Ahmad AE, Basappa NS, Bernhard JC, Bhindi B, Bossé D, Breau RH, Canil CM, Castonguay V, Finelli A, Heng DYC, Inman BA, Kollmannsberger C, Lalani AA, Lavallée LT, Msaouel P, Prendeville S, Soleimani M, Tanguay S, Wood L, Richard PO. Graham J, et al. Among authors: bernhard jc. Can Urol Assoc J. 2024 Nov;18(11):E371-E386. doi: 10.5489/cuaj.9041. Can Urol Assoc J. 2024. PMID: 39500366 Free PMC article. No abstract available.
SAFE: Multi-institutional study of time to complications after robot-assisted partial nephrectomy, selection of a population eligible for outpatient management (UroCCR 90).
Barthe F, Bentellis I, Bernhard JC, Bensalah K, Champy C, Bruyere F, Olivier J, Audenet F, Parier B, Brenier M, Branger N, Lang H, Xylinas E, Boissier R, Rouget B, Chevallier D, Durand M, Ahallal Y. Barthe F, et al. Among authors: bernhard jc. Fr J Urol. 2024 Oct 4;35(1):102753. doi: 10.1016/j.fjurol.2024.102753. Online ahead of print. Fr J Urol. 2024. PMID: 39369793 Free article.
Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129.
Martini A, Bernhard JC, Falagario UG, Herman G, Geshkovska A, Khene ZE, Audenet F, Champy C, Bruyere F, Rolland M, Waeckel T, Lorette M, Doumerc N, Surlemont L, Parier B, Tricard T, Branger N, Michel C, Fiard G, Fontenil A, Vallée M, Guillotreau J, Patard JJ, Joncour C, Boissier R, Ouzaid I, Panthier F, Belas O, Mallet R, Gimel P, DE Vergie S, Bigot P, Beauval JB. Martini A, et al. Among authors: bernhard jc. Minerva Urol Nephrol. 2024 Oct;76(5):578-587. doi: 10.23736/S2724-6051.24.05857-9. Minerva Urol Nephrol. 2024. PMID: 39320248
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, Önal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P. Shuch B, et al. Among authors: bernhard jc. Lancet Oncol. 2024 Oct;25(10):1277-1287. doi: 10.1016/S1470-2045(24)00402-9. Epub 2024 Sep 10. Lancet Oncol. 2024. PMID: 39270701 Free article. Clinical Trial.
219 results